Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells

Jahangir Abdi(Utrecht University), Frank A. Redegeld(Utrecht University)
Blood Cancer Journal
May 31, 2013
Cited by 13


Related Papers